Evidence map›Paper›PMID 34959800›Full record

ReviewNutrients2021

Unveiling Metabolic Phenotype Alterations in Anorexia Nervosa through Metabolomics.

Laura Mayo-Martínez, Francisco J Rupérez, Gabriel Á Martos-Moreno, Montserrat Graell, Coral Barbas, Jesús Argente, Antonia García

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Laura Mayo-MartínezCentre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo-CEU, Montepríncipe Campus, 28660 Madrid, Spain.
Francisco J RupérezCentre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo-CEU, Montepríncipe Campus, 28660 Madrid, Spain.ORCID 0000-0001-6457-6234
Gabriel Á Martos-MorenoDepartments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, 28009 Madrid, Spain.ORCID 0000-0001-5524-2646
Montserrat GraellDepartment of Psychiatry, Hospital Infantil Universitario Niño Jesús, 28009 Madrid, Spain.
Coral BarbasCentre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo-CEU, Montepríncipe Campus, 28660 Madrid, Spain.ORCID 0000-0003-4722-491X
Jesús ArgenteDepartments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, 28009 Madrid, Spain.ORCID 0000-0001-5826-0276
Antonia GarcíaCentre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo-CEU, Montepríncipe Campus, 28660 Madrid, Spain.
Universidad San Pablo CEU · ESInstituto de Salud Carlos III · ESMadrid Institute for Advanced Studies · ES

Funding

Comunidad de Madrid B-2017/BMD-3751 and S2017/BMD3684 MOIR-2Instituto de Salud Carlos III FIS-PI19/00166Ministry of Economy, Industry and Competitiveness RTI2018-095166-B-I00
6 · The paper itself

Abstract

Anorexia nervosa (AN) is a mental disorder characterized by an intense fear of weight gain that affects mainly young women. It courses with a negative body image leading to altered eating behaviors that have devastating physical, metabolic, and psychological consequences for the patients. Although its origin is postulated to be multifactorial, the etiology of AN remains unknown, and this increases the likelihood of chronification and relapsing. Thus, expanding the available knowledge on the pathophysiology of AN is of enormous interest. Metabolomics is proposed as a powerful tool for the elucidation of disease mechanisms and to provide new insights into the diagnosis, treatment, and prognosis of AN. A review of the literature related to studies of AN patients by employing metabolomic strategies to characterize the main alterations associated with the metabolic phenotype of AN during the last 10 years is described. The most common metabolic alterations are derived from chronic starvation, including amino acid, lipid, and carbohydrate disturbances. Nonetheless, recent findings have shifted the attention to gut-microbiota metabolites as possible factors contributing to AN development, progression, and maintenance. We have identified the areas of ongoing research in AN and propose further perspectives to improve our knowledge and understanding of this disease.

Indexed as

MetabolomicsAnorexia NervosaEatingFeeding BehaviorGastrointestinal MicrobiomeHumansPhenotypeStarvationanorexiamass spectrometrymetabolic phenotypemetabolismmetabolomicsmicrobiota

Identifiers

PMID34959800
PMCPMC8706417
OpenAlexW3217492288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.